rtmark
LearnBonds.com

Philip Morris International Inc. (NYSE:PM) Smokes Analysts in Q3

Philip Morris International Inc. showed off its earnings numbers for the three months ending September 2015 on Thursday, October 15 before the bell for the day on in New York. The firm’s earnings came in at $1.24 per share for the quarter while revenue came in at $6.90B.

philip-morris

In the same period of last year, Philip Morris International Inc. managed to earn $1.39 per share. Sales for the same quarter in 2014 came in at $7.90B. In the three months heading into the release of today’s results, Philip Morris International Inc. stock has gained 3.56% of their value.

Here’s what Wall Street expected from Philip Morris International Inc.

Heading into the publication of these numbers, Wall Street forecast that Philip Morris had earned $1.11 per share by consensus. Revenue was thought to have hit $6.76B for the quarter.

17 analysts were following Philip Morris International Inc. in the months before the firm put out these numbers. 2 analysts told clients the firms were a Buy, 5 analysts said they thought investors should make the stock Overweight, 8 analysts reported that the best strategy was to Hold the shares. 2 analysts advised that their readers hold the firm Underweight and none of the analyst thought the best move was to Sell the stock ahead of earnings.

Philip Morris International Inc. earnings in context

Philip Morris International Inc. is a holding company engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States. The Company’s products are sold in more than 180 markets, which include a range of international and local, premium, mid-price and low-price brands. Its premium price brands include Marlboro, Merit, Parliament and Virginia Slims; mid-price brands are L&M and Chesterfield, and international brands include Bond Street, Lark, Muratti, Next, Philip Morris and Red & White.

For the twelve months in 2015 Wall Street thinks that Philip Morris will manage a profit $4.39 per share. The full sales number for the fiscal year is expected to amount to $26.84B. In its prior fiscal year Philip Morris International Inc. made $5.02 per share. Total revenue for the firm’s last fiscal year came in at $29.77B.

Trusted & Regulated Stock & CFD Brokers

Rating

What we like

  • 0% Fees on Stocks
  • 5000+ Stocks, ETFs and other Markets
  • Accepts Paypal Deposits

Min Deposit

$200

Charge per Trade

Zero Commission

Rating

64 traders signed up today

Visit Now

75% of investors lose money when trading CFDs.

Available Assets

  • Total Number of Stocks & Shares5000+
  • US Stocks
  • German Stocks
  • UK Stocks
  • European
  • ETF Stocks
  • IPO
  • Funds
  • Bonds
  • Options
  • Futures
  • CFDs
  • Crypto

Charge per Trade

  • FTSE 100 Zero Commission
  • NASDAQ Zero Commission
  • DAX Zero Commission
  • Facebook Zero Commission
  • Alphabet Zero Commission
  • Tesla Zero Commission
  • Apple Zero Commission
  • Microsoft Zero Commission

Deposit Method

  • Wire Transfer
  • Credit Cards
  • Bank Account
  • Paypall
  • Skrill
  • Neteller

Rating

What we like

  • Sign up today and get $5 free
  • Fractals Available
  • Paypal Available

Min Deposit

$0

Charge per Trade

$1 to $9 PCM

Rating

Visit Now

Investing in financial markets carries risk, you have the potential to lose your total investment.

Available Assets

  • Total Number of Shares999
  • US Stocks
  • German Stocks
  • UK Stocks
  • European Stocks
  • EFTs
  • IPOs
  • Funds
  • Bonds
  • Options
  • Futures
  • CFDs
  • Crypto

Charge per Trade

  • FTSE 100 $1 - $9 per month
  • NASDAQ $1 - $9 per month
  • DAX $1 - $9 per month
  • Facebook $1 - $9 per month
  • Alphabet $1 - $9 per month
  • Telsa $1 - $9 per month
  • Apple $1 - $9 per month
  • Microsoft $1 - $9 per month

Deposit Method

  • Wire Transfer
  • Credit Cards
  • Bank Account
Users should remember that all trading carries risks and users should only invest in regulated firms. Views expressed are those of the writers only. Past performance is no guarantee of future results. The opinions expressed in this Site do not constitute investment advice and independent financial advice should be sought where appropriate. This website is free for you to use but we may receive commission from the companies we feature on this site.
Avatar

Victor Alagbe is a seasoned business and finance writer with a specialty in writing about how to invest for the long-term in healthcare, pharmacology, energy and tech stocks. His long-term focus is on stocks that provide a nice mix of growth and income. For the short term, he passionately writes about trading stock options for the excitement and leverage that stock options offer.